1995 Roussel lecture. Management of adenocarcinoma of the head of the pancreas: 10 Questions for the 1990s

Canadian Journal of Surgery

Volumn 39, Issue 4, 1996, Pages 271-285

  Taylor, Bryce ^a,b  

^a TORONTO GENERAL HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; MITOMYCIN C;

BILIARY TRACT DRAINAGE; CANCER PALLIATIVE THERAPY; CONFERENCE PAPER; HUMAN; PANCREAS ADENOCARCINOMA; PATIENT SELECTION; PREOPERATIVE EVALUATION; PROBLEM SOLVING; STOMACH EMPTYING; TREATMENT OUTCOME; TREATMENT PLANNING;

ADENOCARCINOMA; FORECASTING; HUMANS; PALLIATIVE CARE; PANCREATIC NEOPLASMS; PANCREATICODUODENECTOMY; PATIENT SELECTION; PROGNOSIS;

EID: 0029784451     PISSN: 0008428X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (129)

1. Silverberg E, Borling CC, Squires TS: Cancer statistics, 1990. CA 1990; 40: 9-26
2. American Cancer Society: Cancer Facts and Figures 1991, American Cancer Society, Atlanta, 1991
3. Hirayama T: Epidemiology of pancreatic cancer in Japan. Jpn J Clin Oncol 1989; 19: 208-215
4. Gordis L, Gold EB: Epidemiology of pancreatic cancer. World J Surg 1984; 8: 808-821
5. National Cancer Institute: Annual Cancer Statistics Review 1973-1988, NIH publication no. 91-2789, Department of Health and Human Services, Bethesda, Md, 1991
6. Doll R, Peto R: The causes of cancer: quantitative estimates of the avoidable risks of cancer in the United States today. [review] J Natl Cancer Inst 1981; 66: 1191
7. Williams RR, Horn JW: Association of cancer sites with tobacco and alcohol consumption and socioeconomic status of patients: interview study for the Third National Cancer survey. J Natl Cancer Inst 1977; 58: 525-547
8. Krain LS: The rising incidence of carcinoma of the pancreas - real or apparent? J Surg Oncol 1970; 2: 115-124
9. Wynder EL, Mabuchi K, Maruchi N et al: Epidemiology of cancer of the pancreas. J Natl Cancer Inst 1973; 50: 645-667
10. Nagakawa T, Kobayashi H, Ueno K et al: The pattern of lymph node involvement in carcinoma of the head of the pancreas. Int J Pancreatol 1993; 13: 15-22
11. Nagakawa T, Mori K, Nakano T et al: Perineural invasion of carcinoma of the pancreas and biliary tract. Br J Surg 1993; 80: 619-621
12. Whipple AO, Parsons WB, Mullins CT: Treatment of cancer of the ampulla of Vater. Am Surg 1935; 102: 763-779
13. Gudjonsson B: Cancer of the pancreas: 50 years of surgery. Cancer 1987; 60: 2284-2303
14. Crile G: The advantages of bypass operations over radical pancreatoduodenectomy in the treatment of pancreatic carcinoma. Surg Gynecol Obstet 1970; 130: 1049-1053
15. Shapiro TM: Adenocarcinoma of the pancreas: a statistical analysis of bypass vs. Whipple resection in good risk patients. Ann Surg 1975; 182: 715-721
16. van Heerden JA: In discussion of Cameron JL: Ann Surg 1993; 217: 430-438
17. Crist DW, Sitzmann JV, Cameron JL: Improved hospital mortality after the Whipple operation. Ann Surg 1987; 206: 358-373
18. Cameron JL, Crist DW, Sitzmann JV et al: Factors influencing survival after pancreaticoduodenectomy for pancreatic cancer. Am J Surg 1991; 161: 120-125
19. Willett CG, Lewandrowski K, Warshaw AL et al: Resection margins in carcinoma of the head of the pancreas. Ann Surg 1993; 217: 144-148
20. Jones BA, Langer B, Taylor BR: Periampullary tumours: Which ones should be resected? Am J Surg 1985; 149: 46-52
21. Trede M, Schwall G, Saeger H: Survival after pancreaticoduodenectomy. Ann Surg 1990; 211: 447-158
22. Yeo CJ, Cameron JL, Lillemoe KD et al: Pancreaticoduodenectomy for cancer of the head of the pancreas: 201 patients. Ann Surg 1995; 221-721-733
23. Howard JM: Pancreatico-duodenectomy: forty-one consecutive Whipple resections without an operative mortality. Ann Surg 1968; 168: 629-640
24. Fernandez-del Castillo C, Rattner DW, Warshaw AL: Standards for pancreatic resection in the 1990s. Arch Surg 1995; 130: 295-300
25. Watanapa P, Williamson RCN: Surgical palliation for pancreatic cancer: developments during the past two decades. Br J Surg 1992; 79: 8-20
26. McLeod RS, Taylor BR, Langer B et al: Quality of life, nutritional status, and gastrointestinal hormone profile following the Whipple procedure. Am J Surg 1995; 169: 179-185
27. Ishikawa O, Ohhigashi H, Sasaki Y et al: Practical usefulness of lymphatic and connective tissue clearance for the carcinoma of the pancreas head. Ann Surg 1988; 208: 215-220
28. Manabe T, Ohshio G, Baba N et al: Radical pancreatectomy for ductal cell carcinoma of the head of the pancreas. Cancer 1989; 64: 1132-1137
29. Bakkevold KE, Kambestad B: Long-term survival following radical and palliative treatment of patients with carcinoma of the pancreas and papilla of Vater: the prognostic factors influencing the long-term results. Eur J Surg Oncol 1993; 19: 147-161
30. Bakkevold KE, Kambestad B: Morbidity and mortality after radical and palliative pancreatic cancer surgery. Ann Surg 1993; 217: 356-368
31. Warshaw AL, Swanson RS: Pancreatic cancer in 1988: possibilities and probabilities. Ann Surg 1988; 208: 541-553
32. Ihse I, Lilja P, Arnesjo B et al: Total pancreatectomy for cancer: an appraisal of 65 cases. Ann Surg 1977; 186: 675-680
33. Forrest JF, Longmire WP: Cancer of the pancreas and periampullary region: a study of 279 patients. Ann Surg 1979; 189: 129-138
34. van Heerden JA: Pancreatic resection for carcinoma of the pancreas: Whipple versus total pancrearectomy - an institutional perspective. World J Surg 1984; 8: 880-888
35. van Heerden JA, ReMine WH, Weiland LH et al: Total pancreatectomy for ductal adenocarcinoma of the pancreas. Am J Surg 1981; 142: 308-311
36. ReMine WH, Priestley JT, Judd ES et al: Total pancreatectomy. Ann Surg 1970; 172: 595-604
37. Pliam MB, ReMine WH: Further evaluation of total pancreatectomy. Arch Surg 1975; 110: 506-512
38. Brooks JR, Culebras JM: Cancer of the pancreas. Palliative operation, Whipple procedure, or total pancreatectomy? Am J Surg 1976; 131: 516-520
39. Kummerle F, Ruckert K: Surgical treatment of pancreatic cancer. World J Surg 1984; 8: 889-894
40. Herter FP, Cooperman AM, Ahlborn TN et al: Surgical experience with pancreatic and periampullary cancer. Ann Surg 1982; 195: 274-281
41. Edis AJ, Kieran PD, Taylor WF: Attempted curative resection of ductal carcinoma of the pancreas: review of the Mayo Clinic experience, 1951-1975. Mayo Clin Proc 1980; 55: 531-536
42. Grace PA, Pitt HA, Tompkins RK et al: Decreased morbidity and mortality after pancreaticoduodenectomy. Am J Surg 1986; 151: 141-149
43. Andren-Sandberg A, Ihse I: Factors influencing survial after total pancreatectomy in patients with pancreatic cancer. Ann Surg 1983; 198: 605-610
44. Crist DW, Cameron JL: The current status of the Whipple operation for periampullary carcinoma. Adv Surg 1992; 25: 21-49
45. Fortner JG: Regional pancreatectomy for cancer of the pancreas, ampulla, and other related sites: tumor staging and results. Ann Surg 1984; 199: 418-425
46. Sindelar WF: Clinical experience with regional pancreatectomy for adenocarcinoma of the pancreas. Arch Surg 1989; 124: 127-132
47. Tashiro S, Uchino R, Hiraoka T et al: Surgical indication and significance of portal vein resection in biliary and pancreatic cancer. Surgery 1991; 109: 481-487
48. Farmer DG, Shaked A, Busuttil RW et al: Radical resection combined with liver transplantation for foregut tumours. Am Surg 1993; 59: 806-812
49. Starzl TE, Todo S, Tzakis A et al: Abdominal organ cluster transplantation for the treatment of upper abdominal malignancies. Ann Surg 1989; 210: 374-386
50. Tzakis AG, Todo S, Madariaga J et al: Upper-abdominal exenteration in transplantation for extensive malignancies of the upper abdomen - an update. Transplantation 1991; 51: 727-728
51. Wyatt SH, Fishman EK: Spiral CT of the pancreas. Semin Ultrasound CT MR 1994; 15: 122-132
52. Sterner E, Stark DD, Hahn PF et al: Imaging and pancreatic neoplasms: comparison of MRI and CT. AJR 1989; 152: 487-491
53. Tio TL, Tytgat GN: Endoscopic ultrasonography in staging local resectability of pancreatic and periampullary malignancy. Scand J Gastroenterol Suppl 1986; 123: 135-142
54. Yasuda K, Mukai H, Fujimoto S et al: The diagnosis of pancreatic cancer by endoscopic ultrasonography. Gastrointest Endosc 1988; 34: 1-8
55. Kaufman AR, Sivak MV Jr: Endoscopic ultrasonography in the differential diagnosis of pancreatic disease. Gastrointest Endosc 1989; 35: 214-219
56. Appleton GV, Bathurst NC, Virjee J et al: The value of angiography in the surgical management of pancreatic disease. Ann R Coll Surg Engl 1989; 71: 92-96
57. Mackie CR, Noble HG, Cooper MJ et al: Prospective evaluation of angiography in the diagnosis and management of patients suspected of having pancreatic cancer. Ann Surg 1979; 189: 11-17
58. Warshaw AL, Gu Z, Wittenberg J et al: Preoperative staging and assessment of resectability of pancreatic cancer. Arch Surg 1990; 125: 230-233
59. Warshaw AL, Tepper JE, Shipley WU: Laparoscopy in the staging and planning of therapy for pancreatic cancer. Am J Surg 1986; 151: 76-80
60. Cuschieri A: Laparoscopy for pancreatic cancer: Does it benefit the patient? Eur J Surg Clin Oncol 1988; 14: 41-44
61. Forse RA, Babineau T, Steele G et al: Laparoscopy/thoracoscopy for staging: I. Staging endoscopy in surgical endoscopy. Semin Surg Oncol 1993; 9 (1): 51-55
62. Ivanov S, Keranov S: Laparoscopic assessment of the operability of pancreatic cancer. Khirurgiia (Sofiia) 1989; 42 (1): 12-14
63. Ferrucci JT, Wittenberg J, Margolies MN et al: Malignant seeding of the tract after thin-needle aspiration biopsy. Radiology 1979; 130: 345-346
64. Rashleigh-Bilcher HJ, Russell RC, Lees WR: Cutaneous seeding of pancreatic carcinoma by fine-needle aspiration biopsy. Br J Radiol 1986; 59: 182-183
65. Warshaw AL: Implications of peritoneal cytology for staging of early pancreatic cancer. Am J Surg 1991; 161: 26-30
66. Plainfosse MC, Bouillot JL, Rivaton F et al: The use of operative sonography in carcinoma of the pancreas. World J Surg 1987; 11: 654-658
67. Moosa AR, Altorki N: Pancreatic biopsy. Surg Clin North Am 1983; 63: 1205-1214
68. Buice WS, Walker LG Jr: The role of intraoperative biopsy in the treatment of resectable neoplasms of the pancreas and periampullary region. Am Surg 1989; 55: 307-310
69. Witz M, Shkolnik Z, Dinbar A: Intraoperative pancreatic biopsy - a diagnostic dilemma. J Surg Oncol 1989; 42: 117-119
70. Braasch JW, Gray BN: Considerations that lower pancreatoduodenectomy mortality. Am J Surg 1977; 133: 480-484
71. Nakayama T, Ikeda A, Okuda K: Percutaneous transhepatic drainage of the biliary tract. Gastroenterology 1978; 74: 554-559
72. Pitt HA, Cameron JL, Rostier RG et al: Factors affecting mortality in biliary tract surgery. Am J Surg 1981; 141: 66-72
73. Bailey ME: Endotoxin, bile salts, and renal function in obstructive jaundice. Br J Surg 1976; 63: 774-778
74. Hatfield ARW, Terblanche J, Fataar S et al: Preoperative external biliary drainage in obstructive jaundice. Lancet 1982; 2: 896-899
75. McPherson GA, Benjamin IS, Hodgson HJ et al: Preoperative percutaneous transhepatic biliary drainage: the results of a controlled trial. Br J Surg 1984; 71: 371-375
76. Pitt HA, Gomes AS, Lois JF et al: Does preoperative percutaneous biliary drainage reduce operative risk or increase hospital cost? Ann Surg 1985; 201: 545-553
77. Smith RC, Pooley M, George CRP et al: Preoperative percutaneous transhepatic internal drainage in obstructive jaundice: a randomized controlled trial examining renal function. Surgery 1985; 97: 641-647
78. McPherson GA, Benjamin IS, Habib NA et al: Percutaneous transhepatic drainage in obstructive jaundice: advantages and problems. Br J Surg 1982; 62: 261-264
79. Mueller PR, van Sonnenberg E, Ferrucci JT Jr: Percutaneous biliary drainage: technical and catheter-related problems in 200 procedures. Am J Radiol 1982; 138: 17-23
80. Marcus SG, Cohen H, Ranson JHC: Optimal management of the pancreatic remnant after pancreaticoduodenectomy. Ann Surg 1995; 221: 635-648
81. Yeo CJ, Barry K, Sauter PK et al: Erythromycin accelerates gastric emptying after pancreaticoduodenectomy: a prospective, randomized placebo-controlled trial. Ann Surg 1993; 218: 229-238
82. Buchler M, Friess H, Beger HG et al: Role of octreotide in the prevention of postoperative complications following pancreatic resection. Am J Surg 1992; 163: 125-131
83. Delcore R, Thomas JH, Pierce GE et al: Pancreatogastrostomy: a safe drainage procedure after pancreatoduodenectomy. Surgery 1990; 108: 641-647
84. Morris DM, Ford RS: Pancreaticogastrostomy: preferred reconstruction for Whipple resection. J Surg Res 1993; 54: 122-125
85. Scott HW, Dean RH, Parker T et al: The role of vagotomy in pancreaticoduodenectomy. Ann Surg 1980; 191: 688-696
86. Braasch JW, Deziel DJ, Rossi RL et al: Pyloric and gastric preserving pancreatic resection. Experience with 87 patients. Ann Surg 1986; 204: 411-418
87. Traverso LW, Longmire WP Jr: Preservation of the pylorus in pancreaticoduodenectomy. Surg Gynecol Obstet 1978; 146: 959-962
88. Warshaw AL, Torchiana DL: Delayed gastric emptying after pylorus-preserving pancreaticoduodenectomy. Surg Gynecol Obstet 1985; 160: 1-4
89. Trede M, Schwall G: The complications of pancreatectomy. Ann Surg 1988; 207: 39-47
90. Pellegrini CA, Heck CF, Raper S et al: An analysis of the reduced morbidity and mortality rates after pancreaticoduodenectomy. Arch Surg 1989; 124: 778-781
91. Lea MS, Stahlgren LH: Is resection appropriate for adenocarcinoma of the pancreas? A cost-benefit analysis. Am J Surg 1987; 154: 651-654
92. Gordar TA, Burleyson GP, Tielsch JM et al: The effects of regionalization on cost and outcome for one general high-risk surgical procedure. Ann Surg 1985; 221: 43-49
93. Droste T: Marketing: "centers of excellence" name tag carries clout. Hospitals 1989; 63 (Jan 20): 54
94. Traska MR: In search of centers of excellence: here's what to ask before you send employees who need high-cost high-tech medical procedures to specialty centers. Bus Health 1989; 7 (Sept): 11-16
95. Tytgat GN, Bartelsman JF, Den Hartog Jager FC et al: Upper intestinal and biliary tract endoprosthesis. [review] Dig Dis Sci 1986; 31 (9 Suppl): 57S-76S
96. Speer AG, Cotton PB, MacRae KD: Endoscopic management of malignant biliary obstruction: stents of 10 French gauge are preferable to stems of 8 French gauge. Gastrointest Endosc 1988; 34: 412-417
97. Leung JW, Del Favero G, Cotton PB: Endoscopic biliary prosthesis: a comparison of material. Gastrointest Endosc 1985; 31: 93-95
98. Adam A, Cherry N, Roddie M et al: Self-expandable stainless steel endoprostheses for treatment of malignant bile duct obstruction. AJR 1991; 156: 321-325
99. Rosemurgy AS, Burnett CM, Wasselle JA: A comparison of choledochoenteric bypass and cholecystoenteric bypass in patients with biliary obstruction due to pancreatic cancer. Am Surg 1989; 55: 55-60
100. Sarr MG, Cameron JL: Surgical palliation of unresectable carcinoma of the pancreas. World J Surg 1984; 8: 906-918
101. Gardner AM, Solomou G: Relief of the pain of unresectable carcinoma of pancreas by chemical splanchnicectomy during laparotomy. Ann R Coll Surg Engl 1984; 66: 409-411
102. Whittington R, Dobelbower RR, Mohiuddin M et al: Radiotherapy of unresectable pancreatic carcinoma: a six year experience with 104 patients. Int J Radiat Oncol Biol Phys 1981; 7: 1639-1644
103. Moertel CG, Childs DS Jr, Reitemeier RJ et al: Combined 5-fluorouracil and supervoltage radiation therapy of locally unresectable gastrointestinal cancer. Lancet 1969; 2: 865-867
104. Moertel CG, Frytak S, Hahn BG et al: Therapy of locally unresectable pancreatic carcinoma: a randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-fluorouracil), and high dose radiation + 5-fluorouracil: The Gastrointestinal Tumor Study Group. Cancer 1981; 48: 1705-1710
105. Wagener DH, de Mulder PH: The treatment of locally advanced pancreatic cancer. Anticancer Res 1989; 9: 1009-1012
106. Shibamoto Y, Manabe T, Baba N et al: High dose, external beam and intraoperative radiotherapy in the treatment of resectable and unresectable pancreatic cancer. Int J Radiat Oncol Biol Phys 1990; 19: 605-611
107. Cubilla AL, Fitzgerald PG, Fortner JG: Pancreas cancer - duct cell adenocarcinoma: survival in relation to site, size, stage and type of therapy. J Surg Oncol 1978; 10: 465-482
108. Nitecki SS, Sarr MG, van Heerden JA et al: Long term survival after resection for ductal adenocarcinoma of the pancreas - Is it really improving? Ann Surg 1995; 221: 59-66
109. Merrick HW, Dobelbower RR, Konski AA: Intraoperative radiation therapy for pancreatic, biliary and gastric carcinoma: the US experience. Front Radiat Ther Oncol 1991; 25: 246-257
110. Further evidence of effective combined radiation and chemotherapy following curative resection of pancreatic cancer. Gastrointestinal Tumor Study Group. Cancer 1987; 59: 2006-2010
111. Kaiser MH, Ellenberg SS: Pancreatic cancer: adjuvant combined radiation and chemotherapy following curative resection. Arch Surg 1985; 120: 899-903
112. Pilepich MV, Miller HH: Preoperative irradiation in carcinoma of the pancreas. Cancer 1980; 46: 1945-1949
113. Kopelson G: Curative surgery for adenocarcinoma of the pancreas/ ampulla of Vater: the role of adjuvant pre or postoperative radiation therapy. Int J Radiat Oncol Biol Phys 1983; 9: 911-915
114. Ishikawa O, Ohigashi H, Teshima T et al: Clinical and histopathological appraisal of preoperative irradiation for adenocarcinoma of the pancreatoduodenal region. J Surg Oncol 1989; 40: 143-151
115. Weese JL, Nussbaum ML, Paul AR et al: Increased resectability of locally advanced pancreatic and periampullary carcinoma with neoadjuvant chemoradiotherapy. Int J Pancreatol 1990; 7: 177-185
116. Clark CC, Mitchell PE: Diabetes mellitus and primary carcinoma of the pancreas. Br Med J 1961; 11: 1259-1262
117. Friedman GD, van den Eeden SK: Risk factors for pancreatic cancer: an exploratory study. Int J Epidemiol 1993; 22: 30
118. Benarde MA, Weiss W: Coffee consumption and pancreatic cancer: temporal and spatial correlation. Br Med J (Clin Res Ed) 1982: 284: 400-402
119. Binstock M, Krakow D, Stamler J et al: Coffee and pancreatic cancer: an analysis of international mortality data. Am J Epidemiol 1983; 118: 630-640
120. Hirayama T: Epidemiology of pancreatic cancer in Japan. Jpn J Clin Oncol 1989; 19: 208-215
121. Gold EB, Gordis L, Diener MD et al: Diet and other risk factors for cancer of the pancreas. Cancer 1985; 55: 460-467
122. Frebourg T, Bercoff E, Manchon N et al: The evaluation of CA 19-9 antigen level in the early detection of pancreatic cancer. A prospective study of 866 patients Cancer 1988; 62: 2287-2290
123. Glenn J, Steinberg WM, Kurtzman SH et al: Evaluation of the utility of a radioimmunoassay for serum CA 19-9 levels in patients before and after treatment of carcinoma of the pancreas. J Clin Oncol 1988; 6: 462-468
124. Steinberg W: The clinical utility of the CA 19-9 tumor-associated antigen. Am J Gastroenterol 1990; 85: 350-355
125. Allison DC, Bose KK, Hruban RH et al: Pancreatic cancer cell DNA content correlates with long-term survival after pancreaticoduodenectomy. Ann Surg 1991; 214: 648-656
126. Grunewald K, Lyons J, Frohlich A et al: High frequency of Ki-ras codon 12 mutations in pancreatic adenocarcinomas. Int J Cancer 1989; 43: 1037-1041
127. Hruban RH, van Mansfeld AD, Offerhaus GJ et al: K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymorase chain reaction analysis and allele-specific oligonucleotide hybridization. [review] Am J Pathol 1993; 143: 545-554
128. Kalthoff H, Schmiegel W, Roeder G et al: p53 and K-RAS alterations in pancreatic epithelial cell lesions. Oncogens 1993; 8: 289-298
129. Lumacue JA, Griffen CA, Osman M et al: Familial pancreatic cancer and the genetics of pancreatic cancer. Surg Clin North Am 1995; 75: 845-855